Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survivalDavid M. Gershenson, Charlotte C. Sun, Amir A. Jazaeri et al.|Gynecologic Oncology|2022Cited by 16